Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Dell Technologies Receives Buy Rating from Loop Capital Analyst

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Biotechnology Market Capitalization
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Loop Capital analyst Ananda Baruah has recently started covering Dell Technologies (NYSE: DELL) with a Buy rating and set a Price Target of $125. This optimistic outlook reflects Loop Capital’s belief in the company’s prospects and potential for growth in the market. As a key player in the tech industry, Dell Technologies is poised to capitalize on this endorsement from Loop Capital and further solidify its position in the market.

DELL Stock Analysis: Positive and Negative Movements on February 28, 2024

On February 28, 2024, DELL stock exhibited both positive and negative movements throughout the trading day. According to data from CNN Money, DELL was trading near the top of its 52-week range and above its 200-day simple moving average. However, the price of DELL shares decreased by $1.21, or 1.30%, from the previous market close, closing at $91.56.

DELL experienced a slight rebound in after-hours trading, with the stock rising by $0.64. This after-hours movement suggests that there may be some renewed interest or optimism surrounding DELL.

Investors should consider various factors when analyzing stock performance, including price momentum, moving averages, and trading volume. While the drop in price during regular trading hours may be a cause for concern for some investors, the after-hours rebound could indicate a more positive outlook for DELL in the near term.

It is crucial for investors to conduct thorough research and analysis before making any decisions. By staying informed about market trends and company developments, investors can make more informed choices about their investments in DELL or any other stock.

DELL Stock Analysis: Mixed Performances on February 28, 2024

On February 28, 2024, DELL stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was reported at $101.56 billion, which remained flat compared to the previous year. However, total revenue decreased by 3.6% since the last quarter, indicating a slight decline in sales.

In terms of net income, DELL reported a net income of $2.44 billion for the past year, marking a significant decrease of 56.1% compared to the previous year. However, net income increased by 117.75% since the last quarter, showing a positive trend in profitability.

Earnings per share (EPS) for DELL stood at $3.24 for the past year, reflecting a decrease of 53.83% compared to the previous year. On the other hand, EPS increased by 117.17% since the last quarter, indicating a strong performance in terms of earnings per share.

Overall, DELL stock’s performance on February 28, 2024, was a mix of positive and negative trends. Investors should closely monitor DELL’s financial performance and market trends to make informed decisions regarding their investments in the company.

Tags: DELL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
SO stock news

Life Time Group Anticipates Strong Financial Performance in First Quarter 2024

Tilray Sees Opportunity in Germanys Growing Cannabis Market

Biotechnology Trading online

Ginkgo Bioworks Acquires Proof Diagnostics Advancing Genetic Medicine Through Innovative Technologies

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com